标题
Advances in immunotherapy for glioblastoma multiforme
作者
关键词
-
出版物
Frontiers in Immunology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-10-12
DOI
10.3389/fimmu.2022.944452
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
- (2022) Ugur Sener et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial
- (2022) Tomoki Todo et al. NATURE MEDICINE
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
- (2021) Nikhil C. Munshi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Immunotherapies for Glioblastoma Multiforme
- (2021) Boyuan Huang et al. Frontiers in Immunology
- Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response
- (2021) Eftychia Stavrakaki et al. Cancers
- Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway
- (2021) Thamiris Becker Scheffel et al. Frontiers in Oncology
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Immunotherapy for Glioblastoma: Current Progress and Challenge
- (2021) Miranda W. Yu et al. Frontiers in Immunology
- CTLA-4 correlates with immune and clinical characteristics of glioma
- (2020) Fangkun Liu et al. Cancer Cell International
- Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
- (2020) Dongrui Wang et al. Science Translational Medicine
- Design and Characterization of an “All-in-One” Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines
- (2020) Katharina Zimmermann et al. Cancers
- T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer
- (2020) Keyi Jia et al. Translational Lung Cancer Research
- A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol
- (2020) Nicholas F. Brown et al. BMC CANCER
- Novel Therapies for Glioblastoma
- (2020) Elisa K. Liu et al. Current Neurology and Neuroscience Reports
- A phase I study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral (iTu) injection alone and in combination with durvalumab.
- (2020) Manish R. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
- (2020) Michael Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Differential expression of the T-cell inhibitor TIGIT in glioblastoma and MS
- (2020) Liliana E. Lucca et al. Neurology-Neuroimmunology & Neuroinflammation
- Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
- (2020) Qing Zhang et al. Cell Death & Disease
- PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
- (2020) Tianrui Yang et al. Human Vaccines & Immunotherapeutics
- Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
- (2020) E. Antonio Chiocca et al. Molecular Therapy-Methods & Clinical Development
- PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis
- (2020) Chengcheng Hao et al. Frontiers in Oncology
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Glioblastoma Immune Landscape and the Potential of New Immunotherapies
- (2020) Thomas Daubon et al. Frontiers in Immunology
- Recent Advances in Immune Cell Therapy for Glioblastoma
- (2020) Xianhui Kang et al. Frontiers in Immunology
- Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells
- (2020) Phuong Nguyen et al. Molecular Therapy-Oncolytics
- Effects of oncolytic viruses and viral vectors on immunity in glioblastoma
- (2020) Penghao Liu et al. GENE THERAPY
- IMMU-17. CAR T CELLS TARGETING THE INTEGRIN ALPHAVBETA3 EXHIBIT ROBUST ANTI-TUMOR RESPONSES AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND GLIOBLASTOMA (GBM)
- (2020) Dustin Cobb et al. NEURO-ONCOLOGY
- Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma
- (2020) Timothy F. Cloughesy et al. JAMA Oncology
- Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
- (2020) Oleg Mozhei et al. Cancers
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- The enhanced tumor specificity of TG6002, an armed-oncolytic vaccinia virus deleted in two genes involved in nucleotide metabolism
- (2019) Johann Foloppe et al. Molecular Therapy-Oncolytics
- Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
- (2019) Stephanie L. Goff et al. JOURNAL OF IMMUNOTHERAPY
- Viral vector: potential therapeutic for glioblastoma multiforme
- (2019) Ceera Manikandan et al. CANCER GENE THERAPY
- Targeting Hypoxia Downstream Signaling Protein, CAIX, for CAR-T Cell Therapy against Glioblastoma
- (2019) Jing Cui et al. NEURO-ONCOLOGY
- B7-H3 as a novel CAR-T therapeutic target for glioblastoma
- (2019) Xin Tang et al. Molecular Therapy-Oncolytics
- T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
- (2019) Dong Yang et al. Journal for ImmunoTherapy of Cancer
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
- (2018) John A. Barrett et al. CANCER GENE THERAPY
- Genetic and clinical characterization of B7-H3(CD276) expression and epigenetic regulation in diffuse brain glioma
- (2018) Zhiliang Wang et al. CANCER SCIENCE
- Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients
- (2018) Daniel J Hogan et al. CLINICAL CANCER RESEARCH
- Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients
- (2018) Pedro R. Lowenstein et al. CLINICAL IMMUNOLOGY
- PD-1 pathway and its clinical application: A 20 year journey after discovery of the complete human PD - 1 gene
- (2018) Kristin Nicole Berger et al. GENE
- Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells
- (2018) Bian Hu et al. HUMAN GENE THERAPY
- Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2
- (2018) Taiji Iwasawa et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
- (2018) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment
- (2018) Wouter B L van den Bossche et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
- (2018) Zhenyi An et al. ONCOGENE
- Current Challenges and Opportunities in Treating Glioblastoma
- (2018) Andrea Shergalis et al. PHARMACOLOGICAL REVIEWS
- Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
- (2018) Serena Pellegatta et al. Science Translational Medicine
- Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
- (2018) Adel Samson et al. Science Translational Medicine
- Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature
- (2018) Markus Leitinger et al. Frontiers in Immunology
- TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
- (2018) Alice L. Hung et al. OncoImmunology
- Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
- (2018) Zhongzhen Yi et al. Molecular Therapy-Methods & Clinical Development
- Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma
- (2018) Sarah Harris-Bookman et al. INTERNATIONAL JOURNAL OF CANCER
- Harnessing the immune system in glioblastoma
- (2018) Nicholas F. Brown et al. BRITISH JOURNAL OF CANCER
- Arming oncolytic reovirus with GM-CSF gene to enhance immunity
- (2018) Vera Kemp et al. CANCER GENE THERAPY
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
- (2018) Frederick L Locke et al. LANCET ONCOLOGY
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
- (2017) S. Cuzzubbo et al. EUROPEAN JOURNAL OF CANCER
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model
- (2017) Dwijit GuhaSarkar et al. Molecular Oncology
- Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
- (2017) Karsten Geletneky et al. MOLECULAR THERAPY
- Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
- (2017) Kevin Bielamowicz et al. NEURO-ONCOLOGY
- Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma
- (2017) Jacob J Mandel et al. NEURO-ONCOLOGY
- Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model
- (2017) Leah A. Mitchell et al. NEURO-ONCOLOGY
- CD70, a novel target of CAR T-cell therapy for gliomas
- (2017) Linchun Jin et al. NEURO-ONCOLOGY
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
- (2017) Khun Visith Keu et al. Science Translational Medicine
- Gene Delivery in Neuro-Oncology
- (2017) Karan Dixit et al. Current Oncology Reports
- Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
- (2017) Thomas Shum et al. Cancer Discovery
- Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
- (2017) Giedre Krenciute et al. Cancer Immunology Research
- The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8 + T Cell Anti-tumor Activity
- (2017) Anne Kleijn et al. Molecular Therapy-Oncolytics
- Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates
- (2017) Kevin A. Cassady et al. Molecular Therapy-Oncolytics
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery
- (2016) Chuanling Zhang et al. BIOMATERIALS
- Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
- (2016) Jennifer E. Kim et al. CLINICAL CANCER RESEARCH
- Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
- (2016) Meenakshi Hegde et al. JOURNAL OF CLINICAL INVESTIGATION
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measles to the Rescue: A Review of Oncolytic Measles Virus
- (2016) Sarah Aref et al. Viruses-Basel
- Expression of the galectin-9-Tim-3 pathway in glioma tissues is associated with the clinical manifestations of glioma
- (2016) ZENGJIN LIU et al. Oncology Letters
- Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis
- (2016) Qi Cui et al. Nature Communications
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Horizontal gene transfer events reshape the global landscape of arm race between viruses and homo sapiens
- (2016) Dong-Sheng Chen et al. Scientific Reports
- A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy
- (2016) Tetsuo Oka et al. Scientific Reports
- HER2 expression status in diverse cancers: review of results from 37,992 patients
- (2015) Min Yan et al. CANCER AND METASTASIS REVIEWS
- Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy
- (2015) A. Yonezawa et al. CLINICAL CANCER RESEARCH
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
- (2015) Brenda Auffinger et al. Expert Review of Neurotherapeutics
- Intravenous Administration of Retroviral Replicating Vector, Toca 511, Demonstrates Therapeutic Efficacy in Orthotopic Immune-Competent Mouse Glioma Model
- (2015) Tiffany T. Huang et al. HUMAN GENE THERAPY
- TIGIT predominantly regulates the immune response via regulatory T cells
- (2015) Sema Kurtulus et al. JOURNAL OF CLINICAL INVESTIGATION
- Sui generis: gene therapy and delivery systems for the treatment of glioblastoma
- (2015) J. R. Kane et al. NEURO-ONCOLOGY
- Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma
- (2015) Nan Ji et al. Oncotarget
- Chlorotoxin: A Helpful Natural Scorpion Peptide to Diagnose Glioma and Fight Tumor Invasion
- (2015) Lucie Dardevet et al. Toxins
- The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
- (2015) Brenda Auffinger et al. Expert Review of Neurotherapeutics
- Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
- (2015) Xuekai Zhu et al. Oncotarget
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Adenoviral vector-mediated gene therapy for gliomas: coming of age
- (2014) Maria G Castro et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma
- (2014) Y Shimazu et al. GENE THERAPY
- Intratumoral Decorin Gene Delivery by AAV Vector Inhibits Brain Glioblastomas and Prolongs Survival of Animals by Inducing Cell Differentiation
- (2014) Hsin-I Ma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase 1 Clinical Trial of Intratumoral Reovirus Infusion for the Treatment of Recurrent Malignant Gliomas in Adults
- (2014) Kimberly P Kicielinski et al. MOLECULAR THERAPY
- A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
- (2014) James M Markert et al. MOLECULAR THERAPY
- Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
- (2014) Hong Jiang et al. PLoS One
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy
- (2013) Caspar Kühnöl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
- (2013) Meenakshi Hegde et al. MOLECULAR THERAPY
- Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
- (2013) T. Doucette et al. Cancer Immunology Research
- Molecular Pathways: Rodent Parvoviruses--Mechanisms of Oncolysis and Prospects for Clinical Cancer Treatment
- (2012) J. P. F. Nuesch et al. CLINICAL CANCER RESEARCH
- Tim-3, a negative regulator of anti-tumor immunity
- (2012) Ana Carrizosa Anderson CURRENT OPINION IN IMMUNOLOGY
- Effect of γ34.5 Deletions on Oncolytic Herpes Simplex Virus Activity in Brain Tumors
- (2012) Ryuichi Kanai et al. JOURNAL OF VIROLOGY
- Gene therapy for brain tumors: Basic developments and clinical implementation
- (2012) Hikmat Assi et al. NEUROSCIENCE LETTERS
- High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses
- (2011) Matthias W. Kron et al. JOURNAL OF GENE MEDICINE
- Adenovirus E1A Directly Targets the E2F/DP-1 Complex
- (2011) P. Pelka et al. JOURNAL OF VIROLOGY
- Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
- (2011) D. Ostertag et al. NEURO-ONCOLOGY
- Non-Stem Cell Origin for Oligodendroglioma
- (2010) Anders I. Persson et al. CANCER CELL
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
- (2010) N. Ahmed et al. CLINICAL CANCER RESEARCH
- Improved Killing of Human High-Grade Glioma Cells by Combining Ionizing Radiation with Oncolytic Parvovirus H-1 Infection
- (2010) Karsten Geletneky et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Novel Bicistronic High-Capacity Gutless Adenovirus Vector That Drives Constitutive Expression of Herpes Simplex Virus Type 1 Thymidine Kinase and Tet-Inducible Expression of Flt3L for Glioma Therapeutics
- (2010) M. Puntel et al. JOURNAL OF VIROLOGY
- Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy
- (2010) Z. Khan et al. NEURO-ONCOLOGY
- Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics
- (2010) M. Candolfi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene therapy for high-grade glioma
- (2010) Atsushi Natsume et al. Cell Adhesion & Migration
- Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression
- (2009) Charn-Jung Chang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
- (2009) H. Wakimoto et al. CANCER RESEARCH
- Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
- (2009) Ann-Marie Maatta et al. CURRENT GENE THERAPY
- Combinatorial Control of Suicide Gene Expression by Tissue-specific Promoter and microRNA Regulation for Cancer Therapy
- (2009) Chunxiao Wu et al. MOLECULAR THERAPY
- B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells
- (2009) Yu Yao et al. NEURO-ONCOLOGY
- TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma
- (2008) M Enderlin et al. CANCER GENE THERAPY
- Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
- (2008) J. A. Maxwell et al. CLINICAL CANCER RESEARCH
- Recombinant Oncolytic Poliovirus Eliminates Glioma In Vivo Without Genetic Adaptation to a Pathogenic Phenotype
- (2008) Elena Y Dobrikova et al. MOLECULAR THERAPY
- A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas
- (2008) Peter Forsyth et al. MOLECULAR THERAPY
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
- Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma
- (2008) Shahriar S Yaghoubi et al. Nature clinical practice. Oncology
- Characterization of Herpes Simplex Virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity
- (2002) Mark S. Kokoris et al. PROTEIN SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search